Skip to content

菲布罗动物保健

US · PAHC #2966 按市值排名 上市于 1970
38.82 +0.84 +2.21%
实时 - 追踪5344个代码 - 心跳于364秒前 · 2026-10-16 19:30

✦ 量化股权信号 计算方式说明

增持
  • 机构持股总比例上升了0.6个百分点。

机构持股

机构持股比例
54.05% +0.65pp
机构数量
269
数据截至
2026/Q3 较上一报告期

持股变动 vs 资金流向

方向分歧

机构在上一报告期增持了股份,同时该股在最近20个交易日的主力资金呈净流出——两者方向出现分歧。

机构持股变动数据按季度发布且存在滞后;资金流向数据为每日更新。请将其作为方向性的交叉验证参考,而非精确的择时信号。

持股人类型

Individual/Insider48.47%
Mutual Fund44.37%
Hedge Fund5.91%
Public Company1.50%
Government Pension Fund0.68%
Insurance Company0.68%
Private Company0.61%
Family Office/Trust0.27%

主要股东 截至 2026-09-07

Jack Bendheim 48.16% · 19.56M 股
BlackRock 7.93% · 3.22M 股
FMR 7.78% · 3.16M 股
Vanguard Capital Management, LLC 2.65% · 1.07M 股
Millennium Management LLC 2.62% · 1.06M 股
State Street Global Advisors 2.56% · 1.04M 股
Geode Capital Management, LLC 1.62% · 657.35K 股
Lord, Abbett & Co. LLC 1.61% · 653.31K 股
Dimensional Fund Advisors 1.31% · 531.09K 股
Vanguard Portfolio Management, LLC 1.25% · 508.49K 股

条形长度是相对于此处列出的最大股东而言,并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 17次买入 · 33次卖出

姓名职务持股比例
Jack Bendheim Chairperson & CEO 48.16%
Glenn David Chief Financial Officer 0.12%
E. Corcoran Independent Non-Executive Director 0.10%
Larry Miller Chief Operating Officer 0.08%
Jonathan Bendheim President of MACIE Region, GM of Israel Operations & Director 0.00%
Carol Wrenn Independent Director 0.00%
Daniel Bendheim Executive VP of Corporate Strategy & Director 0.00%
Judith Weinstein Senior Vice President 0.00%
Lisa Escudero Officer 0.00%
Anthony Andolino VP of Finance & Treasurer --

内部人交易 最近的 Form 4 申报记录

日期姓名职务类型股数价格
2026-09-15 Jack Bendheim Chairperson & CEO Intent to Sell (Form 144) -350,000 $35.30
2026-08-05 Jack Bendheim Chairperson & CEO Other Acquisition +12,103 --
2026-08-05 Daniel Bendheim Executive VP of Corporate Strategy & Director Other Acquisition +11,699 --
2026-08-05 Larry Miller Chief Operating Officer Other Acquisition +3,726 --
2026-08-05 Jonathan Bendheim President of MACIE Region, GM of Israel Operations & Director Other Acquisition +2,716 --
2026-08-05 Glenn David Chief Financial Officer Other Acquisition +3,482 --
2026-08-05 Lisa Escudero Officer Other Acquisition +1,547 --
2026-08-05 Judith Weinstein Senior Vice President Other Acquisition +2,478 --
2026-08-05 Patrick Rodriguez -- Other Acquisition +1,503 --
2026-08-03 Jack Bendheim Chairperson & CEO Other Disposition -2,303 $36.60
2026-08-03 Daniel Bendheim Executive VP of Corporate Strategy & Director Other Disposition -486 $36.60
2026-08-03 Larry Miller Chief Operating Officer Other Disposition -635 $36.60
2026-08-03 Glenn David Chief Financial Officer Other Disposition -840 $36.60
2026-08-03 Lisa Escudero Officer Other Disposition -265 $36.60
2026-08-03 Judith Weinstein Senior Vice President Other Disposition -472 $36.60
2026-06-30 Daniel Bendheim Executive VP of Corporate Strategy & Director Other Derivative Acquisition +300,000 --
2026-06-15 Jack Bendheim Chairperson & CEO Intent to Sell (Form 144) -281,600 $31.87
2026-05-28 E. Corcoran Independent Non-Executive Director Open Market Acquisition +10,000 $31.77
2026-05-06 Jack Bendheim Chairperson & CEO Automatic Disposition -18,608 $47.59–58.13
2026-04-29 Jack Bendheim Chairperson & CEO Automatic Disposition -21,120 $52.65–56.69

Form 4 申报记录,每家公司显示最新的一批。"Other Derivative Acquisition"(其他衍生品获取)类目多为限制性股票/期权归属,并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 19:30:05 · 仅供参考,不构成投资建议,也未考虑您的具体情况。

菲布罗动物保健 讨论区 0 条评论

发表评论